NIH P20 funding opportunities: Exploratory Grant
3 NIH notices for P20 (Exploratory Grant) are open and 2 forecast. Planning or building a research center or program.
- Open notices3
- Forecast2
- Projects funded under them3,573
Open NIH P20 notices
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
Open - Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional)
Open - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Open
Forecast P20 notices
- Limited Competition: Community-Partnered Nursing Research Centers for Schools and Colleges of Nursing with Limited NIH Funding (P20 Clinical Trial Optional)
Forecast - Forecast for NINDS Exploratory Grant Program in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research (P20 - Clinical Trial Optional)
Forecast
Institutes that fund P20 projects under these notices
| Institute or center | Projects |
|---|---|
| National Cancer Institute (NCI) | 512 |
| National Institute of General Medical Sciences (NIGMS) | 439 |
| National Heart Lung and Blood Institute (NHLBI) | 377 |
| National Institute on Aging (NIA) | 297 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 282 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 252 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 238 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 173 |
| National Institute on Drug Abuse (NIDA) | 156 |
| National Institute of Mental Health (NIMH) | 118 |
Closed P20 notices
- RFA-HD-27-006: Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)
- PAR-23-257: IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional)
- PAR-23-063: Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
- PAR-23-100: IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)
- PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
- PAR-22-250: Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
- RFA-ES-23-007: Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)
- RFA-DK-22-027: Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed)
- RFA-CA-23-038: Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed)
- PAR-22-239: Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
- PAR-22-163: Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
- RFA-DK-21-032: Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed)
- RFA-HD-22-005: Learning Disabilities Innovation Hubs (P20 Clinical Trial Optional)
Questions people ask
What is an NIH P20?
P20 is NIH's activity code for the Exploratory Grant. Planning or building a research center or program. Each notice sets its own budget limit, project length and due dates.
How many NIH P20 funding opportunities are open?
3 notices are open on Grants.gov, and 2 more are forecast, as of the latest data.